BSF Enterprise plc share price, company news, analysis and interviews

Discover how BSF Enterprise Plc is pioneering cell-based solutions, with a focus on lab-grown leather, biotech innovations, and veterinary breakthroughs.

BSF Enterprise PLC (LON:BSFA), the parent to a portfolio of innovative subsidiary companies developing cell-based tissue engineering solutions to deliver sustainable outcomes across a variety of sectors, has provided the following portfolio update. ●     Lab Grown Leather (LGL): Revolutionising the leather industry with the world’s first and only scaffold-free lab-grown leather, 3D Bio Tissues (3DBT), on behalf of LGL, is producing leather that is 100% pure animal tissue, cultivated entirely in a lab. Building on the team’s success in producing an animal skin tissue measuring up to 10 by 10 cm in size and over 2 mm in thickness, LGL has now developed a codified

BSF Enterprise plc (LON:BSFA), the Main Market listed biotech company and owner of corneal tissue replacement company Kerato Ltd, has announced that Kerato Ltd has entered into a Heads of Terms agreement and research partnership with the University of Montreal in Canada. BSF’s 100% owned Kerato is an independent company established to commercialise new innovations in tissue engineering towards in vitro and in vivo corneal use. As part of this strategy, Kerato will work with the University of Montreal, combining tissue engineering expertise to further develop an in-situ gelling cornea that offers a novel treatment for corneal damage and full thickness perforations.